Patents by Inventor Jason FERNANDES

Jason FERNANDES has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240392271
    Abstract: The disclosure relates to gene repressor systems comprising catalytically-dead Class 2 CRISPR proteins and one or more transcription repressor domains linked to the catalytically-dead Class 2 CRISPR protein as a fusion protein, as well as a guide ribonucleic acid (gRNA); and methods of making and using same.
    Type: Application
    Filed: September 21, 2022
    Publication date: November 28, 2024
    Inventors: Jason FERNANDES, Ross WHITE, Sean HIGGINS, Sarah DENNY, Benjamin OAKES, Emeric Jean Marius CHARLES
  • Publication number: 20240254466
    Abstract: The disclosure relates to gene repressor systems comprising catalytically-dead Class 2 CRISPR proteins and one or more transcription repressor domains linked to the catalytically-dead Class 2 CRISPR protein as a fusion protein, as well as a guide ribonucleic acid (gRNA); and methods of making and using same.
    Type: Application
    Filed: March 21, 2024
    Publication date: August 1, 2024
    Inventors: Jason FERNANDES, Ross WHITE, Sean HIGGINS, Sarah DENNY, Benjamin OAKES, Emeric Jean Marius CHARLES
  • Publication number: 20240124537
    Abstract: Provided herein are gene repressor systems comprising fusion proteins, such as fusion proteins comprising a DNA binding domain such as a TALE, zinc finger or catalytically-dead CRISPR protein and guide nucleic acid (gRNA), which are useful in the repression of a proprotein convertase subtilisin/kexin Type 9 (PCSK9) gene. Also provided are methods of using such systems to repress transcription of PCSK9.
    Type: Application
    Filed: November 21, 2023
    Publication date: April 18, 2024
    Inventors: Jason FERNANDES, Sean HIGGINS, Sarah DENNY, Ross WHITE, Emeric Jean Marius CHARLES, Addison WRIGHT, Benjamin DEMAREE, Manuel MOHR, Wenyuan ZHOU, Benjamin OAKES
  • Publication number: 20240123089
    Abstract: Provided herein are gene repressor systems comprising fusion proteins, such as fusion proteins comprising a DNA binding domain such as a TALE, zinc finger or catalytically-dead CRISPR protein and guide nucleic acid (gRNA), which are useful in the repression of a proprotein convertase subtilisin kexin Type 9 (PCSK9) gene. Also provided are methods of using such systems to repress transcription of PCSK9.
    Type: Application
    Filed: November 21, 2023
    Publication date: April 18, 2024
    Inventors: Jason FERNANDES, Sean HIGGINS, Sarah DENNY, Ross WHITE, Emeric Jean Marius CHARLES, Addison WRIGHT, Benjamin DEMAREE, Manuel MOHR, Wenyuan ZHOU, Benjamin OAKES
  • Publication number: 20240070231
    Abstract: Computer systems, apparatuses, processors, and non-transitory computer-readable storage devices configured for executing a method for generating proactive advisor recommendation using artificial intelligence. The method has the steps of: partitioning a plurality of clients using a clustering model based on data of the plurality of clients for clustering the plurality of clients into a plurality of client clusters; classifying the clients of at least a first client cluster of the plurality of client clusters into a plurality of client classifications by using one or more random-forest classifiers; and generating financial recommendations for the clients of at least a first client classification of the plurality of client classifications.
    Type: Application
    Filed: August 23, 2023
    Publication date: February 29, 2024
    Inventors: Vishal Rakesh JAISWAL, Shashwat REGMI, Sujina Bhadravathi HALESH, Jason FERNANDES, Matthew SHERMAN, Manish SHAH, Venkatesh LOGANATHAN, Aharon KAGEDAN, Lior VELICHOVER, Martin WILDBERGER, Michael PALMER
  • Publication number: 20230183691
    Abstract: Provided herein are delivery particle systems (XDP) useful for the delivery of payloads of any type. In some embodiments, a XDP particle system with tropism for target cells of interest is used to deliver CRISPR/Cas polypeptides (e.g., CasX proteins) and guide nucleic acids (gNA), for the modification of nucleic acids in target cells. Also provided are methods of making and using such XDP to modify the nucleic acids in such cells.
    Type: Application
    Filed: February 3, 2023
    Publication date: June 15, 2023
    Inventors: Jason FERNANDES, Sean HIGGINS, Isabel COLIN, Hannah SPINNER, Matthew GARDNER, Trent GOMBERG, Gayathri VIJAYAKUMAR, Sarah DENNY, Brett T. STAAHL, Maroof ADIL, Benjamin OAKES, Angus SIDORE, Suraj MAKHIJA